LinusBio Raises $16M for Novel Diagnostics Platform that Can Help Diagnose Autism Early
LinusBio raised over $16 million to deliver a novel platform that bridges genomics, the environment, and biological response.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Company News, Diagnostic Technologies |
LinusBio raised over $16 million to deliver a novel platform that bridges genomics, the environment, and biological response.
Read MorePosted by Chris Wolski | Nov 11, 2022 | Sequencing Systems |
Researchers have uncovered new genes associated with autism spectrum disorder (ASD) in the largest autism whole genome sequencing to date.
Read MorePosted by Chris Wolski | Oct 17, 2022 | Molecular Diagnostic Analyzers |
Research underscores the positive outcomes of exome sequencing for individuals with ASD, supporting its use to reach a faster diagnosis.
Read MorePosted by Andy Lundin | Aug 24, 2022 | Research |
Researchers are attempting to determine if artificial intelligence can be used to aid with the early detection of autism spectrum disorder.
Read MorePosted by Andy Lundin | Jan 7, 2022 | Womens Health |
A large study has identified molecular signatures of gestational inflammation linked to the risk of developing autism spectrum disorder (ASD).
Read More